Taurolidine: Cytotoxic and mechanistic evaluation of a novel antineoplastic agent

Cancer Research

Volumn 61, Issue 18, 2001, Pages 6816-6821

  Calabresi, P ^a   Goulette, F A ^a   Darnowski, J W ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; DNA FRAGMENT; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TAUROLIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DNA DEGRADATION; DRUG STRUCTURE; ENZYME DEGRADATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MAXIMUM TOLERATED DOSE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR XENOGRAFT;

3T3 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; DNA FRAGMENTATION; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; MICE; MICE, NUDE; OVARIAN NEOPLASMS; TAURINE; THIADIAZINES; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035884603     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. NMR studies and GC analysis of the antibacterial agent, taurolidine
2. Prevention of peritoneal adhesions after thermal injury using noxythiolin and Taurolin
3. Reduced adherence of microorganisms to human mucosal epithelial cells following treatment with Taurolin, a novel antimicrobial agent
4. Experimental studies with an antibacterial substance, Taurolin
5. The in vitro and in vivo activity of Taurolin against anaerobic pathogenic organisms
6. Sustained anti-adherence activity of taurolidine (Taurolin) and noxythiolin (Noxyflex S) solutions
7. Pharmacological and clinical studies on Taurolin
8. Structural investigation of a new organic antimicrobial-Taurolidine. A spectroscopic study of its stability and equilibria in various solvents
9. The characterization and quantitation by HPLC (high performance liquid chromatography) of the metabolites of Taurolin
10. Electron microscope observations of bacterial cell surface effects due to taurolidine treatment
11. Structural investigation of a new organic antimicrobial: Taurolidine. Analytical study and application to identification and quantification in biological fluids
12. Taurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells
13. Taurolidine inhibits tumor necrosis factor (TNF) toxicity-new evidence of TNF and endotoxin synergy
14. Taurolidine, an antilipopolysaccharide agent, has immunoregulatory properties that are mediated by the amino acid taurine
15. Pentoxifylline cyclosporin A, and taurolidine inhibit endotoxin-stimulated tumor necrosis factor-α production in rat mesangial cell cultures
16. In vitro antibacterial activity of noxythidin and taurolidine
17. Clinical studies on administration of Taurolidine in severe sepsis: A preliminary study
18. Intraperitoneal and intravenous taurolin, without antibiotics in the treatment of 40 cases of peritonitis
19. A controlled trial of Taurolin in established bacterial peritonitis
20. Cancer statistics 2000
21. Results and complications of operative staging in cervical cancer: Experience of the Gynecologic Oncology Group
22. A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group study
23. Gynecologic neoplasmas
24. Antineoplastic effects of Taurolidine in human tumor cell lines
25. Taurolidine inhibits human ovarian tumor cell growth in vitro and in vivo
26. 3′-Azido-3′-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8
27. Human recombinant interferon α-2a plus 3′-azido-3′-deoxythymidine. Synergistic growth inhibition with evidence of impaired DNA repair in human colon adenocarcinoma cells
28. Recombinant interferon α2a synergistically enhances ganciclovir-mediated tumor cell killing in the herpes simplex virus thymidine kinase system
29. Amifostine cytotoxicity and induction of apoptosis in a human myelodysplastic cell line
30. Modulation of p53 expression by human recombinant interferon-a2a correlates with abrogation of cisplatin resistance in a human melanoma cell line
31. Decreased host toxicity in vivo during chronic treatment with 5-fluorouracil
32. Tissue-specific enhancement of uridine utilization and 5-fluorouracil therapy in mice by benzylacyclouridine
33. 5-Fluorouracil enhances azidothymidine cytotoxicity: In vitro, in vivo, and biochemical studies
34. Metabolic consequences of DNA damage: The role of poly(ADP-ribose) polymerase as mediator of the suicide response
35. ADP-ribosylation of proteins. Enzymology and biological significance
36. Role of poly(ADP-ribose) formation in DNA repair
37. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
38. Irreversible binding of poly(ADP-ribose) polymerase cleavage product to DNA ends revealed by atomic force microscopy: Possible role in apoptosis
39. Taurolidine: Mechanism of action of a novel and safe cytotoxic agent for cancer therapy
40. Taurolidine: A novel agent for bone marrow purging
41. Taurolidine. A novel, nontoxic, antineoplastic agent that induces apoptosis in androgen-independent DU145 human prostate tumor cells
42. Inhibition of peritoneal tumor growth and implantation in laparoscopic surgery in a rat model
43. Influence of different gases and intraperitoneal instillation of antiadherent or cytotoxic agents on peritoneal tumor cell growth and implantation with laparoscopic surgery in a rat model
44. New therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy: Results of a tumor model in the rat